BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 889418)

  • 1. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
    Swett C; Cole JO; Shapiro S; Slone D
    Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 7. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
    Baker LA; Cheng LY; Amara IB
    Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.
    Sovner R; Dimascio A
    Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 12. The rabbit syndrome. A peculiar extrapyramidal reaction.
    Villeneuve A
    Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
    Singh MM; Kay SR
    J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects.
    Keepers GA; Casey DE
    Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benztropine prophylaxis of dystonic reactions.
    Stern TA; Anderson WH
    Psychopharmacology (Berl); 1979 Mar; 61(3):261-2. PubMed ID: 36644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
    Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
    Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic benztropine for antiemetic precipitated extrapyramidal symptoms during cancer chemotherapy.
    Mackie A; Hill HF
    J Pain Symptom Manage; 1989 Sep; 4(3):109-10. PubMed ID: 2778356
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal drug-induced heat stroke.
    Forester D
    JACEP; 1978 Jun; 7(6):243-4. PubMed ID: 661049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
    Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L
    J Pediatr; 1989 Jul; 115(1):156-60. PubMed ID: 2661789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.